Anthera Pharmaceuticals Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Anthera Pharmaceuticals is a small biotechnology company based in Hayward, California, focused on developing medicines to address unmet medical needs. Its pipeline includes Sollpura for exocrine pancreatic insufficiency linked to cystic fibrosis in Phase 3 and blisibimod for IgA nephropathy in Phase 2. The firm is publicly listed on the Nasdaq under the ticker ANTH.

These product candidates address diseases with limited or no highly effective therapies and are pursued toward potential commercialization. In February 2018, Anthera announced the completion of the final visit in the primary treatment phase of its Sollpura Phase 3 trial for EPI.

Sign up for free to view info

Company overview Employee directory